相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cerebrospinal fluid outflow: a review of the historical and contemporary evidence for arachnoid villi, perineural routes, and dural lymphatics
Steven T. Proulx
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Transcriptome of HPβCD-treated Niemann-Pick disease type C1 cells highlights GPNMB as a biomarker for therapeutics
Jorge L. Rodriguez-Gil et al.
HUMAN MOLECULAR GENETICS (2021)
Neurodegeneration in Niemann-Pick Type C Disease: An Updated Review on Pharmacological and Non-Pharmacological Approaches to Counteract Brain and Cognitive Impairment
Ida Cariati et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Estimating the prevalence of Niemann-Pick disease type C (NPC) in the United States
Barbara K. Burton et al.
MOLECULAR GENETICS AND METABOLISM (2021)
Niemann-Pick type C disease: cellular pathology and pharmacotherapy
Simon Wheeler et al.
JOURNAL OF NEUROCHEMISTRY (2020)
New variants in Spanish Niemann-Pick type c disease patients
Laura Lopez de Frutos et al.
MOLECULAR BIOLOGY REPORTS (2020)
Long-term survival outcomes of patients withNiemann-Pickdisease type C receiving miglustat treatment: A large retrospective observational study
Marc C. Patterson et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2020)
2-Hydroxypropyl-β-cyclodextrin Ototoxicity in Adult Rats: Rapid Onset and Massive Destruction of Both Inner and Outer Hair Cells Above a Critical Dose
Xiaopeng Liu et al.
NEUROTOXICITY RESEARCH (2020)
Expanded access with intravenous hydroxypropyl-β-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis
Caroline Hastings et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Consensus clinical management guidelines for Niemann-Pick disease type C
Tarekegn Geberhiwot et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Long-Term Treatment of Niemann-Pick Type Cl Disease With Intrathecal 2-Hydroxypropyl-β-Cyclodextrin
Elizabeth Berry-Kravis et al.
PEDIATRIC NEUROLOGY (2018)
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial
Daniel S. Ory et al.
LANCET (2017)
Recommendations for the detection and diagnosis of Niemann-Pick disease type C An update
Marc C. Patterson et al.
NEUROLOGY-CLINICAL PRACTICE (2017)
High incidence of unrecognized visceral/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets
Christopher A. Wassif et al.
GENETICS IN MEDICINE (2016)
CSF, blood-brain barrier, and brain drug delivery
William M. Pardridge
EXPERT OPINION ON DRUG DELIVERY (2016)
Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database
Jackie Imrie et al.
BMC NEUROLOGY (2015)
Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease
Charles H. Vite et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Shear Wave Elastography for Evaluation of Liver Fibrosis
Giovanna Ferraioli et al.
JOURNAL OF ULTRASOUND IN MEDICINE (2014)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Effects of Miglustat on Stabilization of Neurological Disorder in Niemann-Pick Disease Type C: Iranian Pediatric Case Series
Parvaneh Karimzadeh et al.
JOURNAL OF CHILD NEUROLOGY (2013)
Cyclodextrin alleviates neuronal storage of cholesterol in Niemann-Pick C disease without evidence of detectable blood-brain barrier permeability
Charles C. Pontikis et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease
Benny Liu
CLINICAL LIPIDOLOGY (2012)
Normalization of Cholesterol Homeostasis by 2-Hydroxypropyl-β-cyclodextrin in Neurons and Glia from Niemann-Pick C1 (NPC1)-deficient Mice
Kyle B. Peake et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cyclodextrins as functional excipients: Methods to enhance complexation efficiency
Thorsteinn Loftsson et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Hearing Loss and Hair Cell Death in Mice Given the Cholesterol-Chelating Agent Hydroxypropyl-β-Cyclodextrin
Mark A. Crumling et al.
PLOS ONE (2012)
Gastrointestinal disturbances and their management in miglustat-treated patients
Nadia Belmatoug et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Quantitative role of LAL, NPC2, and NPC1 in lysosomal cholesterol processing defined by genetic and pharmacological manipulations
Charina M. Ramirez et al.
JOURNAL OF LIPID RESEARCH (2011)
Unesterified Cholesterol Accumulation in Late Endosomes/Lysosomes Causes Neurodegeneration and Is Prevented by Driving Cholesterol Export from This Compartment
Amal Aqul et al.
JOURNAL OF NEUROSCIENCE (2011)
Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid
Benny Liu et al.
JOURNAL OF LIPID RESEARCH (2010)
Niemann-Pick disease type C
Marie T. Vanier
ORPHANET JOURNAL OF RARE DISEASES (2010)
Weekly Cyclodextrin Administration Normalizes Cholesterol Metabolism in Nearly Every Organ of the Niemann-Pick Type C1 Mouse and Markedly Prolongs Life
Charina M. Ramirez et al.
PEDIATRIC RESEARCH (2010)
Secondary lipid accumulation in lysosomal disease
Steven U. Walkley et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Recommendations on the diagnosis and management of Niemann-Pick disease type C
James E. Wraith et al.
MOLECULAR GENETICS AND METABOLISM (2009)
Saccades in adult Niemann-Pick disease type C reflect frontal, brainstem, and biochemical deficits
L. A. Abel et al.
NEUROLOGY (2009)
Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression
Cristin D. Davidson et al.
PLOS ONE (2009)
Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse
Benny Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Genetic variations and treatments that affect the lifespan of the NPC1 mouse
Benny Liu et al.
JOURNAL OF LIPID RESEARCH (2008)
Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study
Marc C. Patterson et al.
LANCET NEUROLOGY (2007)
Cyclodextrins as pharmaccutical solubilizers
Marcus E. Brewster et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Niemann-Pick type C disease in a 68-year-old patient
G. Trendelenburg et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Determination of 24S-and 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry
I Burkard et al.
JOURNAL OF LIPID RESEARCH (2004)
Identification of 58 novel mutations in Niemann-Pick disease Type C:: Correlation with biochemical phenotype and importance of PTC1-like domains in NPC1
WD Park et al.
HUMAN MUTATION (2003)
Control of cholesterol turnover in the mouse
JM Dietschy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease
F Camargo et al.
LIFE SCIENCES (2001)
分享论文
